Quantcast

Posts related to ‘PROVENGE’

Dendreon Shares Losing House Committee Hope (DNDN)

Posted: February 13, 2008 at 3:34 pm

CNBC's Mike Huckman just announced what is going to be a disappointment for Dendreon (NASDAQ: DNDN) holders, and that may be an understatement.  The House Committee will not be forcing ...
Read Full Story »

Will The E.U. Save Dendreon If The U.S. Won’t? (DNDN)

Posted: January 15, 2008 at 10:07 am

Dendreon Corp. (NASDAQ:DNDN) shares are trading up in early trading on a patent award, and that is after the fairly large gains yesterday.   Dendreon was granted a broad European patent ...
Read Full Story »

Dendreon A Double Already? (DNDN)

Posted: December 13, 2007 at 3:56 pm

If you read 24/WallSt.com's "Ten Stocks That Could Double in 2008" from us, you saw that Dendreon (NASDAQ:DNDN) is on that list.  We weren't expecting a 22% pop in shares ...
Read Full Story »

Dendreon Sets Stage for 2008 for PROVENGE

Posted: October 23, 2007 at 6:55 am

Dendreon (NASDAQ:DNDN) has issued a press release noting that it has completed its target enrollment of 500 patients in phase III IMPACT study of PROVENGE for advanced prostate cancer.  It ...
Read Full Story »

Institutional Buyer Sheds Light on Dendreon (DNDN)

Posted: September 11, 2007 at 10:24 am

An interesting event happened yesterday in the form of an SEC Filing on Dendreon (NASDAQ:DNDN) that ran the stock.  In a fed-filing from yesterday it was disclosed that BNP Paribas ...
Read Full Story »

Looking Beyond Dendreon’s Upcoming Earnings Release (DNDN)

Posted: August 3, 2007 at 11:44 am

Dendreon Corp. (NASDAQ:DNDN) will release earnings next Tuesday, August 7, after the close.  The volatility in shares has dried up considerably as shares have only traded above $8.00 or below ...
Read Full Story »